Código QR (código de barras bidimensional)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus

The role of CD161+CD127+CD8+ T cells in non-small cell lung cancer (NSCLC) patients with diabetes remains unexplored. This study determined the prevalence, phenotype, and function of CD8+ T cell subsets in NSCLC with diabetes. We recruited NSCLC patients (n = 436) treated with anti-PD-1 immunotherap...

Fuld beskrivelse

Na minha lista:
Principais autores: Jingjing Qu, Yuekang Li, Binggen Wu, Qian Shen, Lijun Chen, Wenjia Sun, Bo Wang, Lixiong Ying, Li Wu, Hong Zhou, Jianya Zhou, Jianying Zhou
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis Group 2024-12-01
Serier:OncoImmunology
Fag:
CD161+CD127+CD8+ T cells
diabetes mellitus
immunotherapy
non-small cell lung cancer
predictive biomarkers
Online adgang:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2371575
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker